HQL 60K Softgel Capsule contains Vitamin D3 (Cholecalciferol) at a potency of 60,000 IU per capsule, designed for the treatment and prevention of Vitamin D deficiency and related disorders. Vitamin D3 is a fat-soluble vitamin essential for calcium and phosphorus homeostasis, promoting bone mineralization and maintaining skeletal health. This high-dose formulation is indicated for patients with significant Vitamin D deficiency, osteomalacia, rickets, hypoparathyroidism, and certain cases of osteoporosis requiring rapid replenishment of Vitamin D stores. The softgel capsule facilitates enhanced bioavailability and ease of administration. Upon oral ingestion, Vitamin D3 undergoes hepatic and renal hydroxylation to its active form, calcitriol, which increases intestinal absorption of calcium and phosphate. Regular monitoring of serum 25-hydroxyvitamin D levels is recommended during therapy to avoid toxicity, which may manifest as hypercalcemia, hypercalciuria, and associated symptoms such as nausea, vomiting, and renal impairment. HQL 60K should be used under medical supervision, particularly in patients with renal dysfunction, hyperparathyroidism, or sarcoidosis. This product is contraindicated in patients with hypervitaminosis D or hypersensitivity to any component. Adherence to prescribed dosage and duration is critical to achieving therapeutic benefits while minimizing adverse effects.